Article Text

Download PDFPDF

P169/277  Underlying intracranial atherosclerotic disease is associated with worse outcomes in acute large vessel occlusion undergoing endovascular thrombectomy
  1. Rami Z Morsi1,
  2. Sonam Thind1,
  3. Theodore Karrison1,
  4. Harrison Lee1,
  5. Fadi Nahab2,
  6. Rishi Gupta3,
  7. Julian Carrion Penagos1,
  8. Issam A Awad1,
  9. Elisheva Coleman1,
  10. James R Brorson1,
  11. Cedric Mckoy1,
  12. Jacqueline Morales1,
  13. Scott Mendelson1,
  14. Ali Mansour1,
  15. Shyam Prabhakaran1,
  16. Tareq Kass-Hout1
  1. 1University of Chicago Medical Center, Chicago, USA
  2. 2Emory University, Atlanta, USA
  3. 3WellStar Health System, Marietta, USA
  4. *Live Presentation


Introduction Data on large vessel occlusion (LVO) management due to underlying intracranial atherosclerotic disease (ICAD) is scarce. We hypothesized that patients with ICAD have worse clinical outcomes following mechanical thrombectomy (MT) than those without ICAD.

Aim of Study To investigate outcomes in patients with ICAD who underwent MT

Methods We performed a retrospective analysis of patients who underwent MT for LVO. We compared in-hospital and 90-day mortality, and 90-day modified Rankin Scale (mRS) scores between those with and without ICAD, in unadjusted and adjusting logistic regression models.

Results Among 215 patients (mean age 67.1±16.0 years; 60.5% female; 80.5% Black, median NIHSS score 16), ICAD was present in 38 patients (17.7%). Diabetes and dyslipidemia were more common in those with ICAD (57.9% vs. 38.4%, p=0.027 and

29.0% vs. 14.7%, p=0.035, respectively). Substantial reperfusion (TICI ≥2b) was achieved less often (84.2% vs. 94.4%, p=0.031) but symptomatic ICH was also less common in ICAD patients (0% vs. 9.0%, p=0.054). In-hospital and 90-day mortality were more common (36.8% vs. 15.8%, p=0.003 and 52.6% vs. 26.6%, p=0.002, respectively) and favorable functional outcome (mRS 0–2) at 90 days was less common (7.9% vs. 33.9%, p=0.001) in ICAD patients. ICAD was independently associated with in-hospital mortality (OR=4.1, 95% CI 1.7–9.7),

90-day mortality (OR=3.7, 95% CI 1.6–8.6), and poor functional outcome at 90 days

(OR=5.5, 95% CI 1.6–19.4).

Conclusion Symptomatic ICAD in a predominantly African American cohort is associated with increased odds of mortality and poor functional outcome at 90 days in patients with

LVO undergoing MT.

Disclosure of Interest The authors have nothing to disclose.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.